AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH. GCM. 2026;1(6):709-721. Accessed August 25, 2026. https://econferencia.com/index.php/5/article/view/1216